Affordable Access

Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer.

Authors
Type
Published Article
Journal
Journal of Clinical Oncology
0732-183X
Publisher
American Society of Clinical Oncology
Publication Date
Volume
12
Issue
1
Pages
83–89
Identifiers
PMID: 8270989
Source
Medline

Abstract

With long-term CI of etoposide, a Css greater than 1 or 1.2 micrograms/mL appeared necessary, but not sufficient, to achieve a major response against NSCLC.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F